Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OptimizeRx CorpOPRX · Entity 213 | Director | January 10, 2018 | January 12, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OptimizeRx Corp
Report date January 10, 2018 · Filed January 12, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 812,329 |
Reported balance
After 2018-01-10 transaction · row 1
1 source rowRow 1 · 2018-01-10 · Grant · Acquired 6,250 · Balance 812,329 F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2018 Filed Jan 12, 2018 21:32 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-000484 · f4011018pinney_optimizerx.xml · nonDerivative · entry 1 Pinney Jack T · CIK 0001617854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812,329 F1 · price: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan. Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 19:04 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-010177 · f4063017pinney_optimizerx.xml · nonDerivative · entry 1 Pinney Jack T · CIK 0001617854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 806,079 F1 · price: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan. Read SEC document |
| June 30, 2017 Filed Jun 30, 2017 20:47 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-007053 · f4063017pinney_optimizerx.xml · nonDerivative · entry 1 Pinney Jack T · CIK 0001617854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799,829 F1 · price: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 21:05 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-003341 · f4033117pinney_optimizerx.xml · nonDerivative · entry 1 Pinney Jack T · CIK 0001617854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 793,579 F1 · price: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:12 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-000070 · f4123116pinney_optimizerx.xml · nonDerivative · entry 1 Pinney Jack T · CIK 0001617854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 787,329 F1 · price: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan. Read SEC document |
| December 13, 2016 Filed Dec 21, 2016 22:28 UTC | OptimizeRx Corp OPRX · Entity 213 | PurchaseCommon Stock | 4,000 | $0.80 | $3,200.00 |
DisclosureSEC source: 0001213900-16-019604 · f4121316pinney_optimizerx.xml · nonDerivative · entry 1 Pinney Jack T · CIK 0001617854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,079 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.